NCT02221739View on ClinicalTrials.gov

Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

April 15, 2015

Study Completion Date

October 27, 2015

Conditions

Non-small Cell Lung Cancer (NSCLC)

Interventions

DRUG

Ipilimumab

RADIATION

Radiotherapy (IMRT or 3-D CRT)

Trial Locations (2)

10016

NYU Clinical Cancer Center, New York

NYU Langone Medical Center, Tisch Hospital, New York

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

NYU Langone Health

OTHER